Corporate News
Legend Biotech (LEGN) traded up 0.92 % during the 24‑hour period ending at 07:01 AM Central European Time on Wednesday, 21 January 2026. The current trading price is USD 18.65 on major exchanges.
- Shares outstanding: 194.5 million
- Market capitalization: USD 3.6 billion
- Volume traded (last 24 h): USD 35.3 million
Since the end of the previous month, Legend Biotech has increased 0.65 %. The simple moving average of the last 200 trading days is USD 22.22. The 52‑week high was USD 37.50 on 6 March 2026, and the 52‑week low was USD 16.24 on 2 April 2026.
Recent Performance of Related Stocks
| Stock | 24‑hour change | Current price | Market cap | Additional metrics |
|---|---|---|---|---|
| Beta (BETA) | –0.22 % | USD 17.99 | USD 4.2 billion | – |
| Champion Homes (SKY) | –3.38 % | USD 75.11 | USD 4.2 billion | P/E = 22.54 |
| Xenergy (XE) | +1.74 % | USD 10.54 | USD 4.2 billion | – |
| Griffon (GFF) | –0.20 % | USD 94.99 | USD 4.2 billion | P/E = 19.33 |
| Heartflow (HTFL) | +5.65 % | USD 51.02 | USD 4.2 billion | – |
About Legend Biotech
Legend Biotech Corporation is a biopharmaceutical company focused on developing cell therapies for oncology and other diseases. The company is headquartered in Somerset, United States, and operates within the Health Care sector, serving clients based in New Jersey. More information is available on the company’s website: www.legendbiotech.com . The stock is traded on the Nasdaq exchange.
